D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
2626
DELISTED
Couchbase
BASE
| $1.79M | ﹤0.01% |
97,984
-28,639
| -23% | -$667K |
|
2627
CALL
Ally Financial
ALLY
$13.2B
| $1.79M | ﹤0.01% |
45,000
-59,200
| -57% | -$2.31M |
|
2628
Oscar Health
OSCR
$9.41B
| $1.78M | ﹤0.01% |
112,790
-194,201
| -63% | -$3.57M |
|
2629
CALL
S&P Global
SPGI
$121B
| $1.78M | ﹤0.01% |
4,000
-66,200
| -94% | -$28.4M |
|
2630
Cosan
CSAN
$3.18B
| $1.78M | ﹤0.01% |
182,690
+145,449
| +391% | +$1.58M |
|
2631
ThredUp
TDUP
$746M
| $1.78M | ﹤0.01% |
1,046,201
+119,748
| +13% | +$218K |
|
2632
Sumitomo Mitsui Financial
SMFG
$164B
| $1.78M | ﹤0.01% |
132,614
-261,730
| -66% | -$3.17M |
|
2633
CALL
BioNTech
BNTX
$22.9B
| $1.78M | ﹤0.01% |
22,100
+4,100
| +23% | +$375K |
|
|
SOHU
2634
Sohu.com
SOHU
$362M
| $1.78M | ﹤0.01% |
127,531
-5,134
| -4% | -$61.7K |
|
2635
Rogers Communications
RCI
$18.3B
| $1.77M | ﹤0.01% |
47,952
-301,744
| -86% | -$11.7M |
|
2636
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
| $1.77M | ﹤0.01% |
46,143
-276,499
| -86% | -$10.4M |
|
2637
Crinetics Pharmaceuticals
CRNX
$8.84B
| $1.77M | ﹤0.01% |
39,566
+32,666
| +473% | +$1.51M |
|
2638
Commercial Vehicle Group
CVGI
$154M
| $1.77M | ﹤0.01% |
361,473
+33,025
| +10% | +$187K |
|
2639
CONMED
CNMD
$1.39B
| $1.77M | ﹤0.01% |
25,520
+22,671
| +796% | +$1.65M |
|
2640
Oxford Industries
OXM
$566M
| $1.77M | ﹤0.01% |
+17,640
| New | +$1.86M |
|
2641
CALL
Nano X Imaging
NNOX
$68.2M
| $1.76M | ﹤0.01% |
240,000
+140,000
| +140% | +$1.24M |
|
2642
Luxfer Holdings
LXFR
$456M
| $1.76M | ﹤0.01% |
151,914
+16,290
| +12% | +$181K |
|
|
TSE
2643
DELISTED
Trinseo
TSE
| $1.76M | ﹤0.01% |
761,973
+308,584
| +68% | +$960K |
|
2644
Diamondrock Hospitality Co
DRH
$2.71B
| $1.76M | ﹤0.01% |
+208,029
| New | +$1.81M |
|
2645
CALL
MP Materials
MP
$7.36B
| $1.75M | ﹤0.01% |
137,700
+37,800
| +38% | +$593K |
|
2646
Clean Energy Fuels
CLNE
$427M
| $1.75M | ﹤0.01% |
656,159
-40,632
| -6% | -$105K |
|
|
CHEB.U
2647
DELISTED
Chenghe Acquisition II Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
CHEB.U
| $1.75M | ﹤0.01% |
+175,000
| New | +$1.75M |
|
2648
PUT
Honeywell
HON
$77B
| $1.75M | ﹤0.01% |
8,700
+4,032
| +86% | +$767K |
|
|
GTHX
2649
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.75M | ﹤0.01% |
767,066
-18,193
| -2% | -$69.5K |
|
2650
CALL
Prudential Financial
PRU
$42.4B
| $1.75M | ﹤0.01% |
14,900
-36,100
| -71% | -$4.17M |
|
Similar funds
D.E. Shaw & Co's Q2 2024 Portfolio in Review
As of Q2 2024, D.E. Shaw & Co held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- D.E. Shaw & Co's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- D.E. Shaw & Co added most to Broadcom in Q2 2024, an estimated $520M increase.
- D.E. Shaw & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- D.E. Shaw & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- D.E. Shaw & Co opened 693 new positions and closed 541 in Q2 2024.
- D.E. Shaw & Co's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.